Medpace Holdings (MEDP) Cash from Financing Activities (2015 - 2026)

Medpace Holdings (MEDP) has reported Cash from Financing Activities for 12 consecutive years, with -$288.3 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Cash from Financing Activities rose 46.66% year-over-year to -$288.3 million; the trailing twelve-month figure through Jun 2026 stood at -$249.5 million (up 76.21% YoY), and the FY2025 full-year result was -$860.4 million, down 458.66% from the prior year.
• Cash from Financing Activities retreated to -$288.3 million in Q2 2026 per MEDP's latest filing, from $12.7 million in the prior quarter.
• Across five years, Cash from Financing Activities topped out at $22.7 million in Q4 2025 and bottomed at -$540.6 million in Q2 2025.
• Historically, Cash from Financing Activities has averaged -$124.9 million across 5 years, with a median of -$67.4 million in 2023.
• The sharpest annual moves came in 2024 and 2025: Cash from Financing Activities soared 114.54% in 2024, then slumped 81265.77% in 2025.
• Over 5 years, Cash from Financing Activities stood at -$131.1 million in 2022, then surged by 101.16% to $1.5 million in 2023, then plunged by 11170.85% to -$168.6 million in 2024, then soared by 113.48% to $22.7 million in 2025, then plunged by 1368.6% to -$288.3 million in 2026.
• According to Business Quant data, Cash from Financing Activities over the past three periods registered -$288.3 million, $12.7 million, and $22.7 million for Q2 2026, Q1 2026, and Q4 2025 respectively.